{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T18:35:01Z","timestamp":1788028501644,"version":"build-2784847793"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:00:00Z","timestamp":1760486400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Systematic lymph node dissection (SLND) has long been widely accepted and established as a standard surgical procedure for lung cancer. In recent years, with the increased detection rate of early-stage non-small cell lung cancer (NSCLC) and the advancement of minimally invasive surgery and enhanced recovery concepts, approaches to lymph node dissection have undergone a notable shift. Previous studies have indicated that extensive removal of non-metastatic lymph nodes may offer uncertain clinical benefits. As a result, alternative strategies such as lobe-specific lymph node dissection (L-SLND) and lymph node sampling have gained attention among thoracic surgeons. In recent years, neoadjuvant chemoimmunotherapy for NSCLC has achieved remarkable success, with tumor-draining lymph nodes (TdLNs) playing a pivotal role in the efficacy of immunotherapy. Lymph node preservation strategies may synergize with immunotherapy by maintaining systemic immune surveillance. Conversely, the removal of non-metastatic lymph nodes could disrupt systemic immunity and exert secondary effects on primary tumors or potential micrometastases. This review summarizes the evolution of lymph node dissection strategies in lung cancer surgery and, in the context of encouraging outcomes with immunotherapy, provides new perspectives on future directions for balancing oncological control with immune preservation.<\/jats:p>","DOI":"10.3389\/fonc.2025.1652551","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:25:02Z","timestamp":1760502302000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Balancing oncological control and immune preservation in the immunotherapy era: revisiting lymph node dissection in non-small cell lung cancer"],"prefix":"10.3389","volume":"15","author":[{"given":"Tao","family":"Jing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.5334\/aogh.2419","article-title":"Global epidemiology of lung cancer","volume":"85","author":"Barta","year":"2019","journal-title":"Ann Glob Health"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-2359","article-title":"Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Howington","year":"2013","journal-title":"Chest."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.06.066","article-title":"Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial","volume":"81","author":"Allen","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"1985","journal-title":"N Engl J Med"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e31819cce50","article-title":"Lymph node dissection for lung cancer: significance, strategy, and technique","volume":"4","author":"Watanabe","year":"2009","journal-title":"J Thorac Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-012-1743-5","article-title":"Retrospective analysis of nodal spread patterns according to tumor location in pathological N2 non-small cell lung cancer","volume":"36","author":"Shimada","year":"2012","journal-title":"World J Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-07926-3","article-title":"Lobe-specific lymph node dissection for clinical early-stage (cIA) peripheral non-small cell lung cancer patients: what and how","volume":"27","author":"Deng","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1136\/thx.11.3.172","article-title":"An investigation into the lymphatic and vascular spread of carcinoma of the bronchus","volume":"11","author":"Nohl","year":"1956","journal-title":"Thorax."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2010.02.009","article-title":"Subcarinal lymph node in upper lobe non-small cell lung cancer patients: is selective lymph node dissection valid","volume":"70","author":"Aokage","year":"2010","journal-title":"Lung Cancer"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5223(99)70246-1","article-title":"Lobe-specific extent of systematic lymph node dissection for non-small cell lung carcinomas according to a retrospective study of metastasis and prognosis","volume":"117","author":"Asamura","year":"1999","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s00595-013-0772-5","article-title":"Validity of using lobe-specific regional lymph node stations to assist navigation during lymph node dissection in early stage non-small cell lung cancer patients","volume":"44","author":"Miyoshi","year":"2014","journal-title":"Surg Today"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1055\/s-2006-924626","article-title":"Is lobe-specific lymph node dissection appropriate in lung cancer patients undergoing routine mediastinoscopy","volume":"55","author":"Turna","year":"2007","journal-title":"Thorac Cardiovasc Surg"},{"key":"B13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jtho.2023.09.1443","article-title":"A shift in paradigm: selective lymph node dissection for minimizing oversurgery in early stage lung cancer","volume":"19","author":"Jiang","year":"2024","journal-title":"J Thorac Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2023.02.010","article-title":"Selective mediastinal lymph node dissection strategy for clinical T1N0 invasive lung cancer: A prospective, multicenter, clinical trial","volume":"18","author":"Zhang","year":"2023","journal-title":"J Thorac Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezw439","article-title":"Systematic lymphadenectomy versus sampling of ipsilateral mediastinal lymph-nodes during lobectomy for non-small-cell lung cancer: a systematic review of randomized trials and a meta-analysis","volume":"51","author":"Mokhles","year":"2017","journal-title":"Eur J Cardiothorac Surg"},{"key":"B16","doi-asserted-by":"publisher","first-page":"100516","DOI":"10.1016\/j.jtocrr.2023.100516","article-title":"Clinical benefits of lobe-specific lymph node dissection in surgery for NSCLC: A systematic review and meta-analysis","volume":"4","author":"Woo","year":"2023","journal-title":"JTO Clin Res Rep"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13081399","article-title":"Comparison of the outcomes between systematic lymph node dissection and lobe-specific lymph node dissection for stage I non-small cell lung cancer","volume":"13","author":"Huang","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2023.03.004","article-title":"Lobe-Specific Lymph Node Dissection May be Feasible for Clinical N0 Solid-Predominant Part-Solid Lung Adenocarcinoma With Solid Component Diameter <\/= 2 cm","volume":"24","author":"Wo","year":"2023","journal-title":"Clin Lung Cancer"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyx170","article-title":"A randomized Phase III trial of lobe-specific vs. systematic nodal dissection for clinical Stage I-II non-small cell lung cancer (JCOG1413)","volume":"48","author":"Hishida","year":"2018","journal-title":"Japanese J Clin Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezaf206","article-title":"Quality comparison of mediastinal lymph node dissection between video-assisted thoracic surgery and open thoracotomy: a supplementary analysis of the phase 3 Japan Clinical Oncology Group 1413 trial\u2020","volume":"67","author":"Tsubokawa","year":"2025","journal-title":"Eur J Cardio-thoracic Surgery: Off J Eur Assoc For Cardio-thoracic Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyad110","article-title":"A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer","volume":"53","author":"Handa","year":"2023","journal-title":"Jpn J Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000774","article-title":"Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort study","volume":"110","author":"Deng","year":"2024","journal-title":"Int J Surg"},{"key":"B23","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.immuni.2021.08.019","article-title":"Resident memory CD8(+) T cells in regional lymph nodes mediate immunity to metastatic melanoma","volume":"54","author":"Molodtsov","year":"2021","journal-title":"Immunity."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57121365","article-title":"Permissible outcomes of lobe-specific lymph node dissection for elevated carcinoembryonic antigen in non-small cell lung cancer","volume":"57","author":"Kuroda","year":"2021","journal-title":"Med (Kaunas Lithuania)"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10020-2","article-title":"Systematic versus lobe-specific mediastinal lymphadenectomy for hypermetabolic lung cancer","volume":"28","author":"Handa","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2021.03.232","article-title":"Extent of mediastinal nodal dissection in stage I non-small cell lung cancer with a radiological pure-solid appearance","volume":"47","author":"Hattori","year":"2021","journal-title":"Eur J Surg Oncol J Eur Soc Surg Oncol Br Assoc Surg Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2020.09.012","article-title":"Lobe-specific lymph node dissection in clinical stage IA solid-dominant non-small-cell lung cancer: A propensity score matching study","volume":"22","author":"Zhao","year":"2021","journal-title":"Clin Lung Cancer."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2019.00642","article-title":"Impact of different types of lymphadenectomy combined with different extents of tumor resection on survival outcomes of stage I non-small-cell lung cancer: A large-cohort real-world study","volume":"9","author":"Wang","year":"2019","journal-title":"Front In Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jtho.2016.08.127","article-title":"Lobe-specific lymph node dissection as a standard procedure in surgery for non-small cell lung cancer: A propensity score matching study","volume":"12","author":"Adachi","year":"2017","journal-title":"J Thorac Oncol Off Publ Int Assoc For Study Lung Cancer."},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2016.05.014","article-title":"Lobe-specific nodal dissection for clinical stage I and II NSCLC: Japanese multi-institutional retrospective study using a propensity score analysis","volume":"11","author":"Hishida","year":"2016","journal-title":"J Thorac Oncol Off Publ Int Assoc For Study Lung Cancer."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-3069","article-title":"Lobe-specific mediastinal nodal dissection is sufficient during lobectomy by video-assisted thoracic surgery or thoracotomy for early-stage lung cancer","volume":"144","author":"Shapiro","year":"2013","journal-title":"Chest."},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.119119","article-title":"Comparison of lobe-specific mediastinal lymphadenectomy versus systematic mediastinal lymphadenectomy for clinical stage Tax2081;a Nax2080; Max2080; non-small cell lung cancer","volume":"9","author":"Ma","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezt195","article-title":"Recurrence of mediastinal node cancer after lobe-specific systematic nodal dissection for non-small-cell lung cancer","volume":"44","author":"Maniwa","year":"2013","journal-title":"Eur J Cardio-thoracic Surgery: Off J Eur Assoc For Cardio-thoracic Surg"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-012-1849-9","article-title":"Selective mediastinal lymphadenectomy without intraoperative frozen section examinations for clinical stage I non-small-cell lung cancer: retrospective study of 403 cases","volume":"37","author":"Jiang","year":"2013","journal-title":"World J Surg"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtcvs.2009.07.024","article-title":"Effect of selective lymph node dissection based on patterns of lobe-specific lymph node metastases on patient outcome in patients with resecta ble non-small cell lung cancer: a large-scale retrospective cohort study applying a propensity score","volume":"139","author":"Ishiguro","year":"2010","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2005.09.078","article-title":"Selective mediastinal lymphadenectomy for clinico-surgical stage I non-small cell lung cancer","volume":"81","author":"Okada","year":"2006","journal-title":"Ann Thorac Surg"},{"key":"B37","doi-asserted-by":"publisher","first-page":"12","DOI":"10.21037\/cco-23-137","article-title":"The emerging perioperative treatment paradigm for non-small cell lung cancer: a narrative review","volume":"13","author":"Christopoulos","year":"2024","journal-title":"Chin Clin Oncol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","article-title":"Perioperative pembrolizumab for early-stage non-small-cell lung cancer","volume":"389","author":"Wakelee","year":"2023","journal-title":"N Engl J Med"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2304875","article-title":"Perioperative durvalumab for resecta ble non-small-cell lung cancer","volume":"389","author":"Heymach","year":"2023","journal-title":"N Engl J Med"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2311926","article-title":"Perioperative nivolumab in resecta ble lung cancer","volume":"390","author":"Cascone","year":"2024","journal-title":"New Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2023.24735","article-title":"Perioperative toripalimab plus chemotherapy for patients with resectabl e non-small cell lung cancer: the neotorch randomized clinical trial","volume":"331","author":"Lu","year":"2024","journal-title":"JAMA."},{"key":"B42","doi-asserted-by":"publisher","first-page":"110331","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41392-023-01356-0","article-title":"Tumor-draining lymph node-derived tumor-specific memory CD8(+) T cells: a key player in PD-1\/PD-L1 immunotherapy","volume":"8","author":"Yin","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"B44","doi-asserted-by":"publisher","first-page":"4049","DOI":"10.1016\/j.cell.2022.09.020","article-title":"The primordial differentiation of tumor-specific memory CD8(+) T cells as bona fide responders to PD-1\/PD-L1 blockade in draining lymph nodes","volume":"185","author":"Huang","year":"2022","journal-title":"Cell."},{"key":"B45","doi-asserted-by":"publisher","first-page":"7015","DOI":"10.1038\/s41467-022-34676-w","article-title":"Elective nodal irradiation mitigates local and systemic immunity generated by combination radiation and immunotherapy in head and neck tumors","volume":"13","author":"Darragh","year":"2022","journal-title":"Nat Commun"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-065X.2006.00444.x","article-title":"The tumor-draining lymph node as an immune-privileged site","volume":"213","author":"Munn","year":"2006","journal-title":"Immunol Rev"},{"key":"B47","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.ccell.2020.09.001","article-title":"The PD-1\/PD-L1-checkpoint restrains T cell immunity in tumor-draining lymph nodes","volume":"38","author":"Dammeijer","year":"2020","journal-title":"Cancer Cell"},{"key":"B48","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.162.10.5838","article-title":"Tumor antigens are constitutively presented in the draining lymph nodes","volume":"162","author":"Marzo","year":"1999","journal-title":"J Immunol (Baltimore Md: 1950)."},{"key":"B49","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.1038\/s41467-022-31941-w","article-title":"Lymphatic-preserving treatment sequencing with immune checkpoint inhibition unleashes cDC1-dependent antitumor immunity in HNSCC","volume":"13","author":"Saddawi-Konefka","year":"2022","journal-title":"Nat Commun"},{"key":"B50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.immuni.2022.12.002","article-title":"CD8(+) T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor","volume":"56","author":"Prokhnevska","year":"2023","journal-title":"Immunity."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.immuni.2013.07.012","article-title":"Oncology meets immunology: the cancer-immunity cycle","volume":"39","author":"Chen","year":"2013","journal-title":"Immunity."},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1714089115","article-title":"Anti-PD-1\/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking","volume":"115","author":"Taggart","year":"2018","journal-title":"Proc Natl Acad Sci United States America."},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-021-02934-3","article-title":"Tumour draining lymph node-generated CD8 T cells play a role in controlling lung metastases after a primary tumour is removed but not when adjuvant immunotherapy is used","volume":"70","author":"Fear","year":"2021","journal-title":"Cancer Immunol Immunother."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179401","article-title":"Immune checkpoint therapy: tumor draining lymph nodes in the spotlights","volume":"22","author":"Fransen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1620433114","article-title":"Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity","volume":"114","author":"Chamoto","year":"2017","journal-title":"Proc Natl Acad Sci U S A."},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.137365","article-title":"Importance of lymph node immune responses in MSI-H\/dMMR colorectal cancer","volume":"6","author":"Inamori","year":"2021","journal-title":"JCI Insight"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2021-002485","article-title":"Neoadjuvant immunoradiotherapy results in high rate of complete pathological response and clinical to pathological downstaging in locally advanced head and neck squamous cell carcinoma","volume":"9","author":"Leidner","year":"2021","journal-title":"J Immunother Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30737-3","article-title":"Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial","volume":"22","author":"Lee","year":"2021","journal-title":"Lancet Oncol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00100-1","article-title":"Pembrolizumab plus concurrent chemoradiotherapy versus placebo plus concurrent chemoradiotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (KEYNOTE-412): a randomised, double-blind, phase 3 trial","volume":"25","author":"Machiels","year":"2024","journal-title":"Lancet Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.05.015","article-title":"Let it be: Preserving tumor-draining lymph nodes in the era of immuno-oncology","volume":"42","author":"Saddawi-Konefka","year":"2024","journal-title":"Cancer Cell"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.124507","article-title":"Tumor-draining lymph nodes are pivotal in PD-1\/PD-L1 checkpoint therapy","volume":"3","author":"Fransen","year":"2018","journal-title":"JCI Insight"},{"key":"B62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.immuni.2018.12.021","article-title":"Intratumoral tcf1(+)PD-1(+)CD8(+) T cells with stem-like properties promote tumor control in response to vaccination and checkpoint blockade immunotherapy","volume":"50","author":"Siddiqui","year":"2019","journal-title":"Immunity."},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0312-6","article-title":"Subsets of exhausted CD8(+) T cells differentially mediate tumor control and respond to checkpoint blockade","volume":"20","author":"Miller","year":"2019","journal-title":"Nat Immunol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"5045","DOI":"10.1038\/s41467-021-25188-0","article-title":"Nodal immune flare mimics nodal disease progression following neoadjuvant immune checkpoint inhibitors in non-small cell lung cancer","volume":"12","author":"Cascone","year":"2021","journal-title":"Nat Commun"},{"key":"B65","doi-asserted-by":"publisher","first-page":"104265","DOI":"10.1016\/j.ebiom.2022.104265","article-title":"Multi-scale characterization of tumor-draining lymph nodes in resecta ble lung cancer treated with neoadjuvant immune checkpoint inhibitors","volume":"84","author":"Yang","year":"2022","journal-title":"EBioMedicine."},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-021-03442-1","article-title":"Cell-programmed nutrient partitioning in the tumour microenvironment","volume":"593","author":"Reinfeld","year":"2021","journal-title":"Nature."},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-023-06145-z","article-title":"A machine learning tool to improve prediction of mediastinal lymph node metastases in non-small cell lung cancer using routinely obtainable [(18)F]FDG-PET\/CT parameters","volume":"50","author":"Rogasch","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002405","article-title":"Minimally invasive thoracic surgery 3.0: lessons learned from the history of lung cancer surgery","volume":"267","author":"Cheng","year":"2018","journal-title":". Ann Surg"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.21037\/jtd-22-1527","article-title":"Prognostic significance of lymph node dissection for lung cancer surgery: a narrative review","volume":"15","author":"Ichiki","year":"2023","journal-title":"J Thorac Dis"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09910-8","article-title":"Clinical utility of [(18)F]FDG PET\/CT in the assessment of mediastinal lymph node disease after neoadjuvant chemoimmunotherapy for non-small cell lung cancer","volume":"33","author":"Zhang","year":"2023","journal-title":"Eur Radiol"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2019.04.082","article-title":"Computed tomography histogram approach to predict lymph node metastasis in patients with clinical stage IA lung cancer","volume":"108","author":"Shimada","year":"2019","journal-title":"Ann Thorac Surg"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2019.07.037","article-title":"Prevalence of occult peribronchial N1 nodal metastasis in peripheral clinical N0 small (\u22642 cm) non-small cell lung cancer","volume":"109","author":"Robinson","year":"2020","journal-title":"Ann Thorac Surg"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt166","article-title":"Impact of micropapillary histologic subtype in selecting limited resection vs lobectomy for lung adenocarcinoma of 2cm or smaller","volume":"105","author":"Nitadori","year":"2013","journal-title":"J Natl Cancer Institute."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2013.06.038","article-title":"Development and validation of a clinical prediction model for N2 lymph node metastasis in non-small cell lung cancer","volume":"96","author":"Chen","year":"2013","journal-title":"Ann Thorac Surg"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01508-2018","article-title":"Which definition of a central tumour is more predictive of occult mediastinal metastasis in nonsmall cell lung cancer patients with radiological N0 disease","volume":"53","author":"Shin","year":"2019","journal-title":"Eur Respir J"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2013.10.001","article-title":"The role of the tumor-microenvironment in lung cancer-metastasis and its relationship to potential therapeutic targets","volume":"40","author":"Wood","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"B77","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12943-021-01411-w","article-title":"Tumor-associated exosomes promote lung cancer metastasis through multiple mechanisms","volume":"20","author":"Jiang","year":"2021","journal-title":"Mol Cancer."}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1652551\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T04:25:03Z","timestamp":1760502303000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1652551\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,15]]},"references-count":77,"alternative-id":["10.3389\/fonc.2025.1652551"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1652551","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,15]]},"article-number":"1652551"}}